| Document |
Document Title |
|
WO/2008/060361A2 |
Methods and devices for the repair of articular tissue using collagen material are provided. Compositions of collagen material and related kits are also provided.
|
|
WO/2008/049578A2 |
The invention relates to a method for sterilizing raw, unheated honey, wherein the raw, unheated honey is sterilized by ozonizing it by using an ozone generator. The invention also relates to a honey-based wound care preparation, wherein...
|
|
WO/2008/046541A2 |
A preferred cosmetic and/or dermatological film-forming preparation, comprising at least one hydrophobic gel and at least one hydrophilic gel, wherein the hydrophobic gel is formed by at least one hydrophobic polymer and mineral fats, or...
|
|
WO2007146416B1 |
The present invention relates to compositions that include ß-glucan. More particularly, the present invention relates to a process for producing soluble ß-glucan.
|
|
WO/2008/041218A1 |
The present invention relates to an antimicrobial and immunostimulatory system, applications thereof and a process for the production of the antimicrobial and immunostimulatory system. The present invention provides a storage-stable anti...
|
|
WO/2008/037262A1 |
The present invention relates to a pharmaceutical composition for wound healing or for accelerating wound healing, said composition comprising phosphate ions, iron ions, and copper ions. The relative amounts (w/w) of phospor (P), iron (F...
|
|
WO2007146440B1 |
A method for producing particulate ß-glucan utilizes surfactant extraction to reduce lipid impurities that decompose to volatile organic compounds (VOCs). The resulting particulate ß-glucan is essentially free of VOCs.
|
|
WO/2008/023163A2 |
The present invention provides a composite material comprising fibrinogen or fibrin, or a mixture thereof, and a bioactive glass. The invention also relates to wound dressings and pharmaceutical compositions containing the composite mate...
|
|
WO/2008/023165A2 |
The present invention provides a composite material comprising lactoferrin and a bioactive glass. The invention also relates to pharmaceutical compositions containing the composite material. Further aspects of the invention relate to the...
|
|
WO/2008/015475A1 |
A gel comprises a cross-linked matrix of albumin molecules and polysaccharide molecules having appendant groups that are carboxyl groups 5 or activated derivatives or salts thereof. The albumin is preferably human serum albumin, most pre...
|
|
WO/2008/015453A1 |
The present invention relates to mixtures comprising charge-stabilized metallic nanoparticles and a photosensitiser, and their use as light activated antimicrobials. The present invention also relates to metallic nanoparticle-ligand-phot...
|
|
WO/2008/000888A2 |
The present invention relates to an implant comprising a source of oxygen capable of releasing oxygen in the form of molecular oxygen or reactive oxygen species, and a material selected from the group consisting of biodegradable and/or b...
|
|
WO/2007/142757A2 |
Compositions which self-assemble under physiological conditions are formulate for application to wounds. The formulations include a pharmaceutically acceptable carrier or are provided as part of a medical device or coating. The formulati...
|
|
WO/2007/132244A2 |
A delivery means for delivering a deliverable material to a wound bed comprises a hydrogel (preferably an optionally cross-linked polyvinylalcohol) and a deliverable material comprising: (i) a decomposable material which in the absence o...
|
|
WO/2007/128926A1 |
This invention concerns a biocompatible paste containing an aqueous excipient, which can be used to form a bandage by application of said paste on mucous membranes of the oral cavity or on the skin, characterised in that it contains the ...
|
|
WO/2007/123789A2 |
A film forming composition that includes a polymer having from about 80 mole percent to about 100 mole percent of a hydrophobic component, and from about 0 to about 20 mole percent of a charged component; a bioactive agent; and a solvent...
|
|
WO/2007/121748A2 |
The wound healing process may be augmented by the addition of fibrin sealant. Dependent on the sealant composition and way of application the wound healing process and tissue regeneration may be further accelerated. The present invention...
|
|
WO/2007/120687A2 |
The present invention is a composition, methods of using that composition and kits including that composition, useful for reducing the size and improving the appearance of a closed wound wherein the composition comprises a therapeuticall...
|
|
WO/2007/115781A2 |
The invention relates to biomedical foam articles for wounds, which are obtained by spraying a polymer dispersion onto a wound. The polymer dispersion is transformed into a three-dimensional molded body which adjusts to the three-dimensi...
|
|
WO2007090846B1 |
The invention relates to the use of naturally occurring zeolites as haemostatic agents and/or for producing cosmetic formulations (e.g. toothpaste), or medical formulations. The agents are characterised in that they contain fine granulat...
|
|
WO/2007/114726A1 |
The invention can be used in medicine, in particular for treating wounds, burns and trophic ulcers. The inventive monolayer coating is embodied in the form of a film or gel and consists of rubber latex in a quantity of 25-98 mass% and at...
|
|
WO/2007/099515A2 |
The present invention relates to a thermoplastic absorbent material for the absorption of proteinaceous or serous body fluids, particularly menses. The thermoplastic absorbent material has a better handling towards such fluids, both in t...
|
|
WO/2007/090368A1 |
The invention relates to the discovery that ionic positive thrombocytes that flow in the vessels are attracted by an ionic negative material, whereas thrombocytes are not attracted in stationary blood. The device consists of a coil (1), ...
|
|
WO/2007/088038A1 |
The invention is related to gel preparations capable of absorbing as well as releasing liquid, and the use of such gel preparations in the treatment of wounds.
|
|
WO/2007/074326A1 |
The present invention relates to hemostatic powders comprising a chitosan salt together with at least one inert material. The present invention also relates to hemostatic powders into which fluid penetrability is 0.5 cm or more within 1 ...
|
|
WO/2007/074327A1 |
The present invention relates to a hemostatic powder comprising a chitosan salt together with at least one medical surfactant. At least one inert material may optionally be included. The hemostatic powder may be incorporated into wound d...
|
|
WO/2007/074241A2 |
The invention relates to a silver complex, to the use thereof for an anti-bacterial health or hygiene product and to the product comprising said complex. The silver complex comprises: ionic silver, a compound A selected from all purines ...
|
|
WO/2007/072065A2 |
Topical composition comprising bioactive glass particles and non-volatile silicone fluid.
|
|
WO/2007/068491A1 |
The invention relates to a wound dressing,a wound contact layer and a medicinal composition comprising a hydrophilic base in which hydrocolloids are dispersed, wherein the hydrophilic base comprises at least one emulsifier and the use of...
|
|
WO/2007/070561A2 |
Therapeutic formulations adapted for positive-pressure application for controlling biological fluid at a desired site in a subject, absorbent articles comprising therapeutic formulations, and anti-infective devices coated with therapeuti...
|
|
WO/2007/068490A1 |
The invention relates to a wound contact layer, comprising a preparation with a hydrocolloid dispersion and a support material comprising an antimicrobial metal.
|
|
WO/2007/068492A1 |
The invention relates to a wound dressing, a wound contact layer and a medicinal composition comprising a hydrophilic base in which hydrocolloids are dispersed, wherein the hydrophilic base comprises at least one emulsifier and the use o...
|
|
WO/2007/067866A2 |
The liquid, polymer-containing coating materials of this invention comprise a polymer of a polymerizable, nitrogen-containing, hydrophilic monomer, which may give thermoresponsive properties, and which is copolymerized with a hydrophobic...
|
|
WO/2007/063320A1 |
The present invention relates to a polymer gelator which exhibits controllable liquid to gel phase transition behaviour. The polymer may be of formula A-B-L-B-A where A represents a polymer unit which, when polymer (I) is provided in an ...
|
|
WO/2007/029003A2 |
A method of preparing a hydrogel comprises : (i) reacting a first molecule comprising a carboxylic acid group and second molecule comprising an amine group or an alcohol group with a hydrolase enzyme to form a product comprising an amide...
|
|
WO/2007/016265A2 |
The disclosure generally relates to pressure-sensitive adhesive compositions and self-adhering wound dressings, and more particularly, to pressure-sensitive adhesive compositions comprising a triblock copolymer and a superabsorbent mater...
|
|
WO/2007/014672A2 |
The invention relates to a hydrogel as well as to the production thereof and to its use in modern wound treatment. The hydrogel comprises at least 50 % by weight of water, at least one gel-forming polysaccharide, selected from the group ...
|
|
WO/2007/007115A2 |
The invention provides a method of treating a wound (for example, a chronic ulcerous skin lesion) in a human or non-human mammal (particularly a human). The wound is contacted with a topical hydrogel composition comprising a hydrophilic ...
|
|
WO/2007/007098A2 |
The invention relates to the use of TGF-β3, or agents having TGF-β3 activity, to promote epithelial regeneration. Methods of manufacturing medicaments, and methods of promoting epithelial regeneration are both provided. In particular, ...
|
|
WO/2007/005792A2 |
A composition includes at least one biologically active agent covalently attached to a first polymerizing molecule that is adapted to undergo a free radical polymerization. The first polymerizing molecule retains the ability to undergo f...
|
|
WO/2007/000591A2 |
A material for the treatment or prophylaxis of microbial, including bacterial, infections, comprising a metal species and a polymer, wherein the polymer stabilises the metal species. Compositions and devices comprising the material. A me...
|
|
WO/2006/133523A2 |
The present invention discloses a class of compounds which have an enhancing effect on peroxidase based antimicrobial compositions. The invention relates to pharmaceutical compositions for prolonged topical use comprising enhancing agent...
|
|
WO/2006/135506A2 |
Formulations are described for the treatment by enzymatic debridement of wounds and ulcers. The formulations have a clear, transparent composition that allows for easy visualization of the wound, and are non-staining for easy clean up. T...
|
|
WO/2006/131747A1 |
An applicator for dispensing uniform thickness layers of liquid to surfaces and especially surgical sealants to surgical sites to create, in situ, a surgical incise drape is disclosed. The applicator employs a supported thin layer of foa...
|
|
WO/2006/120454A1 |
The present application relates to a film forming composition for application to mammalian skin, which composition comprises at least one polyurethane based polymer together with at least one acrylate based polymer. The film forming comp...
|
|
WO/2006/113052A2 |
A silver composition comprising silver sulfate and a method of coating the composition on a substrate is disclosed.
|
|
WO/2006/095193A2 |
A skin dressing is adapted, on activation, to release one or more S-nitrosothiols, preferably S-nitroso-L-glutathione. S-nitrosothiols decompose spontaneously to produce nitric oxide, which has beneficial effects on tissues, particularly...
|
|
WO/2006/084911A2 |
A therapeutic treatment device is provided, which comprises a compound comprising a drug and a nitric oxide (NO) eluting polymer arranged to contact a treatment site in or on a body. The device is acting as a booster for drug eluting pat...
|
|
WO/2006/084998A1 |
The invention concerns a method which consists in providing a gelatin gel with concentration ranging between 5 and 30 % and preferably between 15 and 20 %, and in subjecting said gelatin gel to irradiation by means of an ionizing radiati...
|
|
WO/2006/077386A1 |
A device or composition comprising an agent for the coagulation of protein-containing fluids, wherein the agent comprises an inorganic component which is soluble in protein-containing fluids. Use of such a device or composition for the c...
|
